Hong EG, Min KW, Chun S, Chung CH, et al. Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial. Diabetes Obes Metab 2025 Jul 29. doi: 10.1111/dom.16625.
PMID: 40726438